Evolutionary game theory of growth factor production: Implications for tumour heterogeneity and resistance to therapies

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 1056-1062

  Archetti, M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH FACTOR;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL INTERACTION; DIFFUSION; DRUG EFFICACY; EVOLUTION; GAME; GENETIC HETEROGENEITY; HUMAN; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RNA INTERFERENCE; THEORETICAL MODEL;

DRUG RESISTANCE, NEOPLASM; GAME THEORY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS;

EID: 84883136209     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.336     Document Type: Article

References (44)

1. Achilles EG, Fernandez A, Allred EN, Kisker O, Udagawa T, Beecken WD, Flynn E, Folkman J (2001) Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst 93: 1075-1081.
2. Aktipis CA, Nesse RM (2013) Evolutionary foundations for cancer biology. Evol Appl 6(1): 144-159.
3. Amit L, Ben-Aharon I, Vidal L, Leibovici L, Stemmer S (2013) The impact of bevacizumab (avastin) on survival in metastatic solid tumors-A meta-Analysis and systematic review. PLoS ONE 8(1): e51780.
4. Archetti M (2009a) Survival of the steepest: hypersensitivity to mutations as an adaptation to soft selection. J Evol Biol 22: 740-750.
5. Archetti M (2009b) The volunteer's dilemma and the optimal size of a social group. J Theor Biol 261: 475-480.
6. Archetti M, Scheuring I (2011) Coexistence of cooperation and defection in public goods games. Evolution 65: 1140-1148.
7. Archetti M, Scheuring I (2012) Review: game theory of public goods in one-shot social dilemmas without assortment. J Theor Biol 299: 9-20.
8. Axelrod R, Axelrod De, Pienta KJ (2006) Evolution of cooperation among tumor cells. Proc Natl Acad Sci USA 103: 13474-13479.
9. Bach LA, Sumpter DJT, Alsner J, Loeschke V (2003) Spatial evolutionary games of interaction among generic cancer cells. J Theor Med 5: 47-58.
10. Basanta D, Deutsch A (2008) A Game Theoretical Perspective On The Somatic Evolution Of Cancer. In: Bellomo N, Chaplain M, De Angelis E (eds), Selected Topics On Cancer Modelling: Genesis Evolution Inmune Competition Therapy. Birkhauser: Boston, MA, USA.
11. Basanta D, Hatzikirou H, Deutsch A (2008a) Studying the emergence of invasiveness in tumours using game theory. Eur Phys J 63: 393-397.
12. Basanta D, Scott JG, Fishman MN, Ayala G, Hayward SW, Anderson AR (2012) Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. Br J Cancer 106: 174-181.
13. Basanta D, Scott JG, Rockne R, Swanson KR, Anderson AR (2011) The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view. Phys Biol 8: 015016
14. Basanta D, Simon M, Hatzikirou H, Deutsch A (2008b) Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif 41: 980-987.
15. Bernstein S (1912) Démonstration du théorème de Weierstrass fondée sur le calcul des probabilities. Comm Soc Math Kharkov 13: 1-2.
16. Cairns J (1975) Mutation selection and the natural history of cancer. Nature 255: 197-200.
17. Crespi B, Summers K (2005) Evolutionary biology of cancer. Trends Ecol Evol 20: 545-552.
18. Dexter DL, Leith JT (1986) Tumor heterogeneity and drug resistance. J Clin Oncol 4: 244-257.
19. Dingli D, Chalub FA, Santos FC, Van Segbroeck S, Pacheco JM (2009) Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells. Br J Cancer 101: 1130-1136.
20. Eungdamrong NJ, Iyengar R (2004) Modeling cell signalling networks. Biol Cell 96: 355-362.
21. Gatenby R, Gillies RJ (2008) A microenvironmental model of carcinogenesis. Nat Rev Cancer 8: 56-61.
22. Gatenby RA, Maini P (2003) Cancer summed up. Nature 421: 321.
23. Gerstung M, Nakhoul H, Beerenwinkel N (2011) Evolutionary games with affine fitness functions: applications to cancer. Dynam Games Appl 1: 370-385.
24. Gonzalez-Garcia I, Sole RV, Costa J (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA 99: 13085-13089.
25. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481: 306-313.
26. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70
27. Hemker HC, Hemker PW (1969) General kinetics of enzyme cascades. Proc R Soc Lon Ser B 173: 411-420.
28. Hofbauer J, Sigmund K (1998) Evolutionary Games and Population Dynamics. Cambridge University Press: Cambridge, UK.
29. Iwasa Y, Michor F (2011) Evolutionary dynamics of intratumor heterogeneity. PLoS One 6: e17866.
30. Jouanneau J, Moens G, Bourgeois Y, Poupon MF, Thiery JP (1994) A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc Natl Acad Sci USA 91: 286-290.
31. Lambert G, Estévez-Salmeron L, Oh S, Liao D, Emerson BM, Tlsty TD, Austin RH (2011) An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer 11: 375-382.
32. Lorentz GG (1953) Bernstein Polynomials. University of Toronto Press: Toronto, Canada.
33. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38: 468-473.
34. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochem Biophys Acta 1805: 105-117.
35. Mendes P (1997) Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22: 361-363.
36. Merlo LMF, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
37. Nagy JD (2004) Competition and natural selection in a mathematical model of cancer. Bull Math Biol 66: 663-687.
38. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194: 23-28.
39. Pepper JW (2012) Drugs that target pathogen public goods are robust against evolved drug resistance. Evolut Appl 5(7): 757-761.
40. Perc M, Gómez-Gardeñes J, Szolnoki A, Floría LM, Moreno Y (2013) Evolutionary dynamics of group interactions on structured populations: a review. J R Soc Interface 10: 20120997.
41. Phillips GM (2003) Interpolation and Approximation by Polynomials. Chapter 7. Springer: Berlin, Germany.
42. Ricard J, Noat G (1986) Catalytic efficiency, kinetic co-operativity of oligometric enzymes and evolution. J Theor Biol 123: 431-451.
43. Tomlinson IP (1997) Game-Theory models of interactions between tumour cells. Eur J Cancer 33: 1495-1500.
44. Tomlinson IP, Bodmer WF (1997) Modelling consequences of interactions between tumour cells. Br J Cancer 75: 157-160.